Press Releases
Home › Press Releases
The news index is intended for investors and media professionals who are looking to learn more about Angiotech. We hope you find this information useful and if you can't find what you are looking for, please feel free to contact us.
All press releases and other information listed below were, to the best of Angiotech's knowledge, timely and accurate when issued. However, the passage of time can render information stale, and you should not rely on the continued accuracy of any such material beyond the date of issuance. Angiotech does not assume the obligation to update this information. All viewers should carefully check the dates of issuance of the material contained in the Angiotech site.
2006
- December 11Angiotech announces closing of senior floating rate notes due 2013
- November 30Angiotech announces pricing of senior floating rate notes due 2013
- November 27Proposed Offering of Senior Floating Rate Notes Due 2013
- November 16Angiotech Submits Application for European Regulatory Approval for its Vascular Wrap™ Product
- November 9Angiotech's Vascular Wrap™ trial results demonstrate reduced incidence of amputation
- November 8Notice of Conference Call and Webcast
- November 1Angiotech Pharmaceuticals Reports Third Quarter Results
- October 26TAXUS® Stents Demonstrate Excellent Efficacy and Safety in Studies Presented at TCT 2006
- October 25Angiotech Pharmaceuticals Files Preliminary Short Form Prospectus and Registration Statement
- October 19Notice of conference call and webcast - Third quarter 2006 financial results for Angiotech Pharmaceuticals, Inc.
- September 29Angiotech Co-Founders Win Top Prize for Innovation from Ernest C. Manning Awards Foundation
- September 17Positive Preclinical Data on Vascular Wrap™ Presented at Vascular Conference
- August 24Angiotech receives European approval to market innovative Contour Threads™ product line
- August 17New treatment aims to improve quality of life for hemodialysis patients
- August 3Angiotech Pharmaceuticals Reports Second Quarter Results
- July 20Angiotech Selects Independent Sales Rep in Japan for Contour Threads™ Product Line
- July 20Notice Of Conference Call and Webcast Second Quarter 2006 Financial Results For Angiotech Pharmaceuticals, Inc.
- July 6Angiotech appoints Jeffrey P. Walker as Senior Vice President, Research and Development
- June 28Angiotech Pharmaceuticals Completes Acquisition of Quill Medical, Inc.
- May 25Angiotech Pharmaceuticals to acquire Quill Medical Inc.
- May 25Angiotech provides 2006 and 2007 financial update at its annual analyst day
- May 17TAXUS® coronary stent system cited by EuroIntervention for superiority in diabetic patients
- May 16Moderate-Release Taxus® Express™ Coronary Stent System Demonstrates Sustained Long-Term Outcomes in High-Risk Patients
- May 16TAXUS® Liberte™ Stent System Receives European Approval for Three Complex Coronary Procedures
- May 16Taxus ATLAS Trial Supports Superior Deliverability and Proven Outcomes of Taxus® Liberte™ Stent System
- May 9Angiotech Pharmaceuticals and Genzyme Corporation Form Collaboration to Develop Innovative Surgical Oncology Treatments
- May 9Angiotech Pharmaceuticals, Inc. announces results for the first quarter of 2006
- May 3Boston Scientific and Angiotech Win Patent Infringement Case Against Sahajanand in the Netherlands
- April 27Angiotech Pharmaceuticals, Inc. First Quarter 2006 Financial Results Conference Call
- April 7Angiotech Presents Positive Adhibit™ Data At The 19th Annual European Congress Of Obstetrics And Gynecology
- March 29ACC data show numerical trend favoring TAXUS® coronary stent system
- March 29Angiotech announces license agreement between Surgical Specialties Corporation and Collagen Matrix Technologies Inc. for Dermalogen™ injectable dermal filler products
- March 23Angiotech Pharmaceuticals Closes Acquisition of American Medical Instruments Holdings, Inc.
- March 16Pricing of Senior Subordinated Notes due 2014
- March 15Acquisition Notification Requirements in Compliance with Hart-Scott-Rodino Act
- March 15JAMA article says TAXUS® stents superior to brachytherapy in the treatment of in-stent restenosis
- March 14ARRIVE II registry demonstrates low 2.5 percent TAXUS-related re-intervention rate in complex lesions
- March 12STENT Registry Data Favors TAXUS Over CYPHER In The Most Complex Diabetic Patients
- March 12Excellent In-Stent Restenosis Clinical Trial Results Reported For TAXUS Stent System
- March 8Angiotech partner submits final module for TAXUS® Liberte™ coronary stent system application
- March 7Angiotech partner to release broad range of clinical study results on market-leading TAXUS® Coronary Stent System at ACC 2006
- March 3Proposed Offering of Senior Subordinated Notes due 2014
- March 2Angiotech Pharmaceuticals, Inc. Announces Results For The Quarter And Year Ended December 31, 2005
- February 24Angiotech to appeal UK judgment regarding UK patent
- February 24Angiotech to webcast conference call discussing fourth quarter 2005 financial results
- February 16Angiotech files Hart-Scott-Rodino Notification for AMI acquisition
- February 15Angiotech partner announces French reimbursement for TAXUS® Liberte™ paclitaxel-eluting coronary stent system
- February 1Angiotech Pharmaceuticals to Acquire American Medical Instruments Holdings, Inc. (US)
- January 30Angiotech Pharmaceuticals Comments on Market Movement Research Note Inaccurate
- January 5Angiotech Initiates Anti-Infective CVC U.S. Pivotal Study - Advancing novel approach to prevent medical device infections
News
Quick Links
© Copyright 2010 Angiotech. All Rights Reserved.